Sepsis and Septic Shock Flashcards
Sepsis-3 definition of Sepsis
Life-threatening organ dysfunction caused by dysregulated host response to infection
Sepsis-3 definition of Septic shock
Sepsis with - Persistent hypotension requiring vasopressors to maintain MAP>65mmHg - Serum lactate > 2 mmol/L despite adequate volume resuscitation
Host body defence
- Physical barrier: skin, mucosa, epithelial lining
- Innate immune system: IgA in GI, dendritic cells and macrophages
- Adaptive immune system - lymphocytes, immunoglobulins
Origin of sepsis
Breach of integrity of host barrier (physical or immunological)
Organisms enter bloodstream creating septic state
Three phases of sepsis development
- Bacterial toxin release
- Mediator release
- Effects of specific excessive mediators
Bacterial toxin release
- Bacterial invasion into body tissues
- May/may not be neutralised/cleared by immune system
- Gram -ve LPS
- Gram +ve LTA/MAMP
Endotoxin mediator release and mechanism
ANTI-INFLAMMATORY (Th2)
- Gram -ve toxin (LPS) binds to LPS binding protein which binds to macrophage which releases mediators
- Gram +ve toxin (LTA) binds directly to macrophages which releases mediators
Exotoxin mediator release and mechanism
PRO-INFLAMMATORY (Th1)
- Gram +ve releases superantigens (TSST/SPE) which binds to T-lymphocyte
- T-lymphocytes activate macrophage and endothelial cells
- Macrophages release IL-1 and TNF-alpha
- Endothelial cells release NO
Th1 mediator role on sepsis
Pro-inflammatory
- TNF-alpha
- Interleukin-1 interferon gamma (INF-g)
Th2 mediator role on sepsis
Anti-inflammatory
- Interleukin-10
- IL-1Ra
Pro-inflammatory (TNF-a, INF-g) effects
SEPTIC SHOCK
- Endothelial cell-leukocyte adhesion
- Release arachidonic acid metabolites
- Complement activation
- Vasodilatation by NO
- Increase coagulation (release of tissue factors and membrane coagulants)
- Hyperthermia (TNF-a)
Anti-Inflammatory effects
IMMUNOPARALYSIS
- Inhibit TNF-a
- Augment acute phase reaction
- Inhibit coagulation system activation
- -ve feedback to pro-inflammatory mediators
Clinical features: Host factors
- Age
- Co-morbidities
- Immunosuppression (acquired, drug-induced, congenital)
- Previous splenectomy
Clinical features: Organism factors
- Gram +ve or -ve
- Virulence factors: MRSA, toxin secretion, ESBL, KPC
- Bioburden
Clinical features: Environmental factors
- Occupation
- Travel
- Hospitalisation